Adrenocortical carcinoma (ACC), a rare cancer originating in the adrenal cortex, comprises a minute fraction of overall cancer cases. Its subtle symptoms pose diagnostic challenges, necessitating intensified research efforts. In the realm of cancer research, ACC is a focal point for unraveling its intricate genetic and molecular underpinnings. Through genomic sequencing, pivotal mutations linked to ACC are identified, unveiling potential therapeutic targets. Moreover, emphasis is laid on refining diagnostic modalities and biomarkers to facilitate early detection and prognosis prediction. Collaborative ventures among researchers and clinicians aim at optimizing treatment paradigms, encompassing surgery, chemotherapy, and radiation therapy, to augment patient outcomes. Despite its rarity, persistent investigative pursuits aim to decode the complexities surrounding ACC, promising advancements in diagnosis, treatment, and patient care.
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Revolutionizing psychological care in oncology: A comprehensive review of emerging technologies and their impact on cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : A systematic review of medical art therapy for cancer patients
Manijeh Firoozi, University of Tehran, Iran (Islamic Republic of)
Title : Effect of heterosteroids derived from sapogenin in PI3K/AKT/mTOR and apoptosis pathways in breast cancer cells
Nadia Leney Olazo Marquez, Benemérita Universidad Autónoma de Puebla, Mexico
Title : In search of common path in cancerous point mutations
Ratan Kumar Sarkar, Independent Researcher, India